Karl Anderson
About Karl Anderson
Karl Anderson is a Senior Research Associate at Bristol Myers Squibb in Seattle, Washington, with extensive experience in molecular biology and cell therapy process development.
Current Role at Bristol Myers Squibb
Karl Anderson is currently serving as a Senior Research Associate at Bristol Myers Squibb in Seattle, Washington, United States. In this role, he focuses on various aspects of molecular biology and cell therapy process development. His work includes the optimization of scale-down models to enable high throughput studies of CAR (Chimeric Antigen Receptor) and TCR (T-cell Receptor) cell therapies. Anderson's contributions are instrumental in enhancing the effectiveness and efficiency of gene editing processes in both autologous and allogeneic cell therapy programs.
Previous Experience at Adaptive Biotechnologies Corp.
Karl Anderson has prior experience working at Adaptive Biotechnologies Corp., where he served as a Research and Development Intern for three months in 2019. This position, located in the Greater Seattle Area, allowed him to gain practical experience in the biotechnological field, further building his expertise in molecular biology and synthetic biology applications.
University of Washington Research Roles
Karl Anderson has been involved in various research roles at the University of Washington. From 2018 to 2020, he worked as an Undergraduate Researcher, focusing on biochemistry and molecular biology projects. Additionally, from 2017 to 2021, he served as a Research Advisor at the Washington iGEM - UW iGEM, where he mentored other researchers and contributed to synthetic biology initiatives. Anderson's extensive research experience at the university was crucial in shaping his career in cell therapy and molecular biology.
Education in Biochemistry and Molecular Biology
Karl Anderson earned his Bachelor's degree in Biochemistry and Molecular Biology from the University of Washington, where he studied from 2016 to 2020. His academic background provided a strong foundation for his career in research and development, particularly in the realms of synthetic biology and cell therapy.
Work at Virginia Mason Institute
Prior to his current role, Karl Anderson worked as an Undergraduate Researcher at Virginia Mason Institute from 2017 to 2018. During this eight-month tenure, he gained valuable research experience, which contributed to his growing expertise in molecular biology and gene editing technologies.